Check out our most popular compounded medications! Get Started
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used to treat conditions such as Hypertension, Angina, Heart Failure, Atrial Fibrillation, and Myocardial Infarction.
Licensed to fill prescriptions for patients in RI, MA, CT, NY, NJ, NH, FL and ME.
Prescriber? Sign in or create an account for prescription details and order forms.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) is a specialized medication designed to treat a range of cardiovascular conditions, including hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. This unique formulation is crafted with Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, metoprolol tartrate, over an extended period of time.
The slow-release mechanism of this formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for those medications that require a controlled and prolonged release profile. This gradual release helps to minimize the risk of side effects and ensures the medication's effectiveness.
Metoprolol tartrate, the active ingredient in this formulation, is a beta-blocker. It functions by blocking the action of certain hormones in the body, such as adrenaline. This action helps to lower the heart rate and blood pressure, thereby alleviating the symptoms of hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction.
It is crucial to take this medication as prescribed by your healthcare provider and to adhere to all instructions meticulously. If you have any queries or concerns about this medication, please do not hesitate to contact your healthcare provider or pharmacist.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) is a specially formulated medication designed for the treatment of various cardiovascular conditions such as hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. This medication is a beta-blocker, which functions by inhibiting the action of certain natural chemicals in the body, including epinephrine, on the heart and blood vessels. This action results in a reduction of the heart rate, blood pressure, and strain on the heart.
Additionally, Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) is used to prevent angina, a type of chest pain, and to enhance survival rates following a heart attack.
This medication is available in both immediate-release and extended-release formulations. The extended-release formulation, which includes Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free), is primarily used for the treatment of hypertension, angina, and heart failure, and to reduce the risk of mortality following a heart attack. The immediate-release formulation is typically used for the treatment of atrial fibrillation and the prevention of migraine headaches.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) is formulated with Methocel E4M, a type of controlled-release polymer. This allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reducing the frequency of dosing, and improving patient compliance, particularly for medications that require a controlled and prolonged release profile.
Patients are advised to take Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) as directed by their healthcare provider. It is important not to discontinue the use of this medication without first consulting with a healthcare provider. If you have any questions about Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) or its use in treating any of the aforementioned conditions, please consult with a healthcare professional.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) is a specialized medication designed to manage various cardiovascular conditions such as hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. This medication functions by inhibiting the action of certain chemicals in the body that can trigger the heart to beat faster and with more force. By doing so, it aids in reducing blood pressure, enhancing blood flow, and minimizing the risk of heart attack and stroke.
The unique slow release formulation of Metoprolol Tartrate is achieved through the use of Methocel E4M, a controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This sustained release profile offers several benefits including consistent therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
By providing a steady, consistent level of medication in the body over a longer period of time, the slow release formulation of Metoprolol Tartrate helps to mitigate the risk of side effects and ensure optimal efficacy of the medication. When taken as directed, Metoprolol Tartrate can effectively alleviate the symptoms of hypertension, angina, heart failure, atrial fibrillation, and myocardial infarction. For any queries regarding this formulation or its mechanism of action, please feel free to contact us.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules are versatile in their therapeutic applications. They can be used to manage a variety of conditions including migraine headaches, tremors, and anxiety disorders. The capsules can be used to alleviate chest pain caused by coronary artery disease and to decrease the risk of mortality post-heart attack.
Metoprolol Tartrate 25 mg Slow Release Capsules (Gluten Free) are also beneficial in treating certain types of irregular heartbeats, such as atrial flutter and atrial fibrillation. Furthermore, they can be used to manage high blood pressure in adults and children aged 6 years and above. If you have any queries regarding the use of this formulation for any of these conditions, please do not hesitate to contact us.
Metoprolol Tartrate 25 mg Slow Release Capsules is a medication that is formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The slow release formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer that is used in the formulation of Metoprolol Tartrate 25 mg Slow Release Capsules. It helps in the gradual release of the medication over an extended period of time.
Due to its slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Yes, Metoprolol Tartrate 25 mg Slow Release Capsules is a gluten-free medication.
Metoprolol Tartrate 25 mg Slow Release Capsules offers sustained therapeutic effects due to its slow release formulation. This means that the medication continues to work over an extended period of time.
Yes, the slow release formulation of Metoprolol Tartrate 25 mg Slow Release Capsules can improve patient compliance. This is because the reduced dosing frequency makes it easier for patients to adhere to their medication schedule.
A controlled and prolonged release profile means that the medication is released gradually over an extended period of time. This allows for sustained therapeutic effects and reduced dosing frequency.
Metoprolol Tartrate 25 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It is important to discuss your medical history and any other medications you are currently taking with your healthcare provider before starting this medication.
If you miss a dose of Metoprolol Tartrate 25 mg Slow Release Capsules, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
